Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Photo of a man holding an open book, his reading glasses on the table, face not visible. © Photo by Tamara Gak on Unsplash

Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies.

Cullen, A. E., Palmer-Cooper, E. C., Hardwick, M., Vaggers, S., Crowley, H., Pollak, T. A., & Lennox, B. R. 

The Lancet Psychiatry 8.2 (2021): 109-120.

 

Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)

Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu L-M, Tomei G, Pollard R, Vincent S-A, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, Hosseini AA, Harrower T, Buckely C, Coles A.

Trials, (2019), 20:331

 

Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)

B Lennox, G Tomei, S-A Vincent, K Yeeles, R Pollard, EC Palmer-Cooper, P Jones, M Zandi, A Coles.

J Neurol Neurosurg Psychiatry Published Online First: (11 June 2018). doi: 10.1136/jnnp-2018-318124

 

Psychosis: an autoimmune disease?

A Al-Diwani, T Pollak, S Irani, B Lennox

Immunology, (2017) (epub ahead of print) DOI: 10.1111/imm.12795

 

Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study

B Lennox, EC Palmer-Cooper, T Pollak, J Hainsworth, J Marks, L Jacobson, B Lang

The Lancet Psychiatry, 2016, 4 (1).

 

Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission

L Scoriels, RM Salek, E Goodby, D Grainger, AM Dean, JA West, JL Griffin

Translational psychiatry, 2015, 5 (3)

 

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

GM Khandaker, L Cousins, J Deakin, BR Lennox, R Yolken, PB Jones

The Lancet Psychiatry, 2015, 2 (3), 258-270

 

N-methyl D-Aspartate receptor autoantibodies in psychiatric illness

MS Zandi, B Lennox, A Vincent

Biological Psychiatry, 2015

 

The Oxford Experience: Clinical Features And Outcomes of 25 NMDAR-Ab Positive Patients Including Those With Atypical Presentations (P5. 189)

K Morris, C Buckley, B Lennox, Y Hacohen, E Coutinho, A Vincent

Neurology 82 (10 Supplement), 2014, P5. 189-P5. 189

 

Autoimmune encephalitis: a potentially treatable cause of mental disorder

H Rickards, S Jacob, B Lennox, T Nicholson

Advances in psychiatric treatment, 2014,  20 (2), 92-100

 

Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: A description of a treated case series

MS Zandi, JB Deakin, K Morris, C Buckley, L Jacobson, L Scoriels,

Schizophrenia Research, 2014

 

Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes

MS Zandi, RW Paterson, MA Ellul, L Jacobson, A Al-Diwani, JL Jones

J Neurology, Neurosurgery & Psychiatry, 2014

 

Young people's views of UK mental health services

J Plaistow, K Masson, D Koch, J Wilson, RM Stark, PB Jones, BR Lennox

Early intervention in psychiatry, 2014, 8 (1), 12-23

 

Movement disorders and psychiatry. Five new things.

G Cummins, M Zandi, RA Barker

Neurology Clinical Practice, 2014

 

Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia

E Needham, MS Zandi

Journal of Neurology, 2014

 

Long term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis

JWL Brown, PJ Martin, JW Thorpe, AW Michell, AJ Coles, AL Cox

Journal of Neuroimmunology, 2014

 

Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis

J Deakin, BR Lennox, MS Zandi

Biological psychiatry, 2014, 75 (4), 284-291

 

Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis

A Fornito, BJ Harrison, E Goodby, A Dean, C Ooi, PJ Nathan, BR Lennox

JAMA psychiatry, 2013, 70 (11), 1143-1151

 

Psychotic symptoms in young people warrant urgent referral.

J Deakin, B Lennox

The Practitioner, 2013, 257 (1759), 25-8, 3

 

Defining and treating leucine-rich glioma inactivated 1 antibody associated autoimmunity

MS Zandi

Brain, 2013,  136 (10), 2933-2935

 

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre

RW Paterson, MS Zandi, R Armstrong, A Vincent, JM Schott

Journal of Neurology, Neurosurgery & Psychiatry, 2013

 

Antibody-mediated encephalitis: a treatable cause of schizophrenia

BR Lennox, AJ Coles, A Vincent

The British Journal of Psychiatry, 2012, 200 (2) 92-94

 

Two interesting cases of MMDAR enchepalitis and a typical but seronegative case with ovarian teratoma

M Ellul, S Sawcer, AJ Coles, MS Zandi

Journal of Neurology, Neurosurgery & Psychiatry, 2012,  83 (Suppl 2), A7-A7

 

Disease-relevant autoantibodies in first episode schizophrenia

MS Zandi, SR Irani, B Lang, P Waters, PB Jones, P McKenna, AJ Coles,

Journal of neurology, 2011, 258 (4), 686-688

 

POI06 Rituximab in neuropsychiatric systemic lupus erythematosus: a retrospective study of the Cambridge experience

M Zandi, F Catapano, S Burns, FC Hall, KGC Smith, DRW Jayne,

Journal of Neurology, Neurosurgery & Psychiatry, 2010, 81 (11), e54-e54

 

 

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

SR Irani, K Bera, P Waters, L Zuliani, S Maxwell, MS Zandi, MA Friese, ...

Brain, 2010, 133 (6), 1655-1667